bold = Main text
Part, Chapter, Paragraphgrey = Comment text
7504 II, 5. 5. 3 | Berger K, Koehne-Volland R, Rieke J, Simonow A, Brandstaedter
7505 II, 5. 11. 3 | Laukkanen A, luukkaala T, Riekki R, Turjanmaa K, Varjonen
7506 II, 6. 3. 2 | against TB, isoniazid and rifampicin, (multi-drug resistance,
7507 II, 5. 6. 6 | and Management (Edited by: Riggs BL, Melton LJ, III). Lippincott-Raven
7508 IV, 13. 2. 3 | is shown in the seventh (right-hand) column.~5. HIV/AIDS: Human
7509 III, 10. 4. 5 | rather than that of its rightful host, usually a duck. “Swimmer'
7510 II, 8. 2. 1 | disabilities in Europe may thus rightfully expect that policy makers
7511 II, 9. 5. 3 | employers’ inflexibility and rigid state pension rules if taking
7512 II, 5. 5. 3 | 104:182-191.~Pugliatti M, Riise T, Sotgiu MA, et al (2005):
7513 III, 10. 4. 2 | process~management~ ~ ~RIVM/RIKILT, 2002;~Konings et al., 2003~ ~ ~
7514 II, 5. 5. 3 | Multiple Sclerosis Platform and RIMS, Rehabilitation in Multiple
7515 II, 5. 11. 7 | eczema eds T Ruzicka, J Ring, B Pryzbilla). London: Springer-Verlag,
7516 III, 10. 2. 1 | the use of fluoride mouth rinses, gels, toothpastes and the
7517 I, 2. 7 | geographical proximity of Rio de Janeiro with its 19 million
7518 IV, 11. 6. 4 | et al, 2003). Even if the risk-adjustment mechanisms improved in the
7519 III, 10. 2. 1 | the information exchange, risk-assessment and control of new psychoactive
7520 III, 10. 4. 2 | Scientific colloquium on “Risk-benefits analysis of foods: methods
7521 III, 10. 4. 2 | hazard-benefit analysis or risk-chance [for benefit] analysis for
7522 II, 9. 3. 2 | these techniques are not risk-free and raise ethical issues
7523 IV, 11. 6. 3 | from such population-based risk-pooling arrangements towards out-of-pocket
7524 III, 10. 4. 5 | reasons for the application of risk-reduction measures, whereas the protection
7525 II, 5. 5. 2 | www.alzscot.org/downloads/riskreductionbooklet.pdf]~ ~ ~British Heart Foundation (
7526 II, 5. 5. 3 | 343;938-952.~Peterlin B, Ristic S, Sepcic J, et al (2006):
7527 II, 5. 5. 3 | contact” and “repetitive, ritualistic behaviour, which must be
7528 II, 5. 12. 7 | E, Sanchez-Hernandez E, Rivero M, Vergara M, Martin -~ ~
7529 III, 10. 3. 4 | planning and maintenance of riverways, improved early warning
7530 IV, 13. 9 | food in the Netherlands. – RIVM-2006~ ~WHO (2003): The World
7531 II, 5. 5.Int | in Belgium and the Nethe rlands.~ ~Depression: The EURODEP
7532 II, 5. 2. 6 | Nevertheless, it is important to rmember that all these policies,
7533 III, 10. 3. 2 | and (to a lesser extend) road-runoff and discharge from dental
7534 II, 7. 4. 3 | accidents among vulnerable road-users (Körmer and Smolka, 2008).~ ~
7535 II, 5. 3. 9 | Micheli A, Santaquilani M, Roazzi P, Lisi D, EUROCARE Working
7536 II, 9. 5. 6 | Edited by Isidore S. Obot & Robin Room~Available at:~htt ~ ~
7537 II, 5. 6. 6 | rheumatoid arthritis in Rochester, Minnesota: a study of incidence,
7538 II, 5. 12. 7 | Ioannou G, Doust J, Rockey DC (2003): Terlipressin
7539 II, 5. 5. 3 | repetitive hand-wringing, body rocking, and social withdrawal.
7540 III, 10. 3. 1 | uranium-containing soils and rocks. The most important pathway
7541 III, 10. 2. 1 | Clinical Practice Guideline. Rockville, MD: US Department of Health
7542 II, 5. 5. 3 | Voelker MD, Wallace RB, Rodnitzky RL (1998): The health burdens
7543 III, 10. 2. 1 | Aranceta Bartrina J, Pérez Rodrigo C, Saavedra Santana P, Peña
7544 II, 9. 3. 3 | YouthNet Program).~Klavs I, Rodrigues LC, Wellings K, Weiss HA,
7545 III, 10. 2. 4 | D, Bock, A.K., Klein C, Rodriguez-Cerezo E (2003): Institute of Prospective
7546 III, 10. 5. 1 | 569.~Milstead TM, Miles R, Röbbel N. (2006): Housing and Neighborhood
7547 II, 5. 5.Int(15)| Prince MJ, Reischies F, Roelands M, Skoog I, Turrina C, deVries
7548 II, 8. 2. 1 | retardation (IQ 50-70) (Roeleveld et al, 1997; Felce et al,
7549 II, 9. 1. 2 | Goujard J, Steinbicker V, Roesch C, McDonnell R, Scarano
7550 III, 10. 2. 1 | 1243-1258.~ ~Linseisen J, Rohrmann S, Norat T, Gonzalez CA,
7551 II, 5. 11. 7 | Verboom P, Hakkaart-van Roijen L, et al (2002): The cost
7552 III, 10. 1. 3 | Collins JJ, Kroutil LA, Roland EJ, Moore-Gurrera M (1997):
7553 II, 5. 8. 7 | Postma DS, Pieters WR, Roldaan AC, Wouters EF (2006):on
7554 II, 5. 5. 3 | of general health, pain, role-emotion, and social function, regardless
7555 II, 5. 3. 2 | statute laws or professional roll regulations. These constraints
7556 I, 2. 10. 3 | concerned with the large-scale roll-out of public interest services,
7557 II, 5. 5. 3 | Brewis M, Poskanzer DC, Rolland C, Miller H (1966): Neurological
7558 II, 5. 7. 6 | RenalPatientView, which is being rolled out in a number or renal
7559 II, 9. 3. 3 | Metrics 2:5~Kirby D, Laris BA, Rolleri L (2006): Impact of sex
7560 III, 10. 2. 4 | Holford TR, Gallagher RP, Rollinson S, Bracci PM, Cerhan JR,
7561 II, 5. 5. 3 | in Mures County, Romania. Rom J Neurol Psychiatry 32:115-
7562 II, 5. 8. 7 | 370: 797-799.~ ~Fabbri LM, Romagnoli M, Corbetta L, Casoni G,
7563 III, 10. 2. 4 | Becker N, Hartge P, Zheng T, Roman E, Holly EA, Boffetta P,
7564 III, 10. 2. 1 | Arnault N, Bellisle F, Romano MC, Lehingue Y, Frelut ML,
7565 II, 5. 5. 3 | 66 (suppl. 10)~Knapp M, Romeo R, Beecham J (2007): The
7566 IV, 12. 5 | 2002 ; Robine, Jagger and Romieu, 2001). This survey, conducted
7567 II, 5. 6. 6 | huisartspraktijk~ ~van Saase JL, van Romunde LK, Cats A, Vandenbroucke
7568 I, 2. 7 | live in houses with green roofs that look like gardens,
7569 II, 5. 5. 3 | R, Ben-Shlomo Y, Lees A, Rooney C, Burn D (2005): Population
7570 II, 5. 5. 3 | 1926.~van de Vijver DA, Roos RA, Jansen PA, Porsius AJ,
7571 III, 10. 2. 1 | T, Mourão I, Moreira P, Rosado V (2004): Prevalence of
7572 III, 10. 3. 1 | Ruosteenoja E, A Schaffrath Rosario A, Tirmarche M, Tomáek L,
7573 III, 10. 5. 2 | O'Reilly G, O'Reilly D, Rosato M, Connolly S (2007): Urban
7574 II, 5. 8. 7 | S, Stewart A, Lamont C, Roseman P, Didsbury P (2004): A
7575 IV, 12. 10 | the baseline~data from the ROSIE (Research Outcome~Study
7576 II, 5. 10. 7 | R, Sheikh A, Strachan D, Ross Anderson H (2003): Increasing
7577 III, 10. 2. 1 | Österberg E, Rehm J, Room R and Rossow I (2003): Alcohol: No Ordinary
7578 II, 9. 1. 2 | P, Reuvers M, Robert E, Rost van Tonningen M, Scialli
7579 III, 10. 5. 1 | issues (e.g. UNHabitat, EU, ROSTAT, WHO, UNECE, etc.). As the
7580 IV, 11. 3. 1 | specific types of courses or rotations to be provided by an institution
7581 II, 7. 4. 4 | osteoarthritis after ruptures of rotator cuff, often result in high
7582 IV, 12. 1 | Security Justice Data P rotecti on~ ~ ~Protection of Data~
7583 II, 5. 7. 7 | JB, Greene T, Rogers N, Roth D (1999): A more accurate
7584 II, 5. 5. 3 | sclerosis. Neurology 26:20-22.~Rothwell PM, Charlton D (1998): High
7585 III, 10. 3. 4 | regions of Targovishte, Rousse, Velico Tarnovo, Stara Zagora,
7586 IV, 12. 5 | national data gathering routines, are~- Population statistics (
7587 II, 9. 5. 6 | Williams).New York, US: RoutledgeFalmer.~ ~Beral V 2003: Breast
7588 II, 5. 15. 6 | Wilson DA, Kanavos P, Ubel P, Rovira J (2007): Assessing the
7589 II, 8. 2. 1 | Costello, Simpson, Patel & Rowe1998; Mason & Scior 2004). Visual
7590 II, 5. 6. 6 | Allison T, Brammah T, Busby H, Roxby M, Simmons A, Williams G (
7591 II, 5. 8. 7 | Miravitlles M, de la Roza C, Morera J, Montemayor
7592 II, 5. 5. 3 | The combined proportion of RP-MS and SP-MS ranged from 4% (
7593 IV, 12. 10 | direction and priorities of the RPII, including, inter alia,
7594 II, 5. 10. 7 | Oude Elberink JNG, Pumphrey RSH, Stahl Skov P, van Ree R,
7595 IV, 11. 6. 4 | Social Security Department (RSZ/ONSS). The National Institute
7596 III, 10. 4. 5 | grida.no/soe.cfm?country=RU~ ~WHO Europe (2007): Population
7597 III, 10. 3. 1 | Oberaigner W, Pershagen G, Ruano-Ravina A, Ruosteenoja E, A Schaffrath
7598 III, 10. 6. 2 | keeping streets clean from rubbish, helping older people from
7599 II, 5. 5. 3 | 400-405.~Chrischilles EA, Rubenstein LM, Voelker MD, Wallace
7600 II, 5. 8. 7 | 23: 402-406.~ ~Bilde L, Rud Svenning A, Dollerup J,
7601 III, 10. 2. 5 | Ispanovic-Radojkovic V, Rudic N, Tamminen T, Turunen M-M,
7602 I, 2. 2 | the world.~ ~The report by Rudiger Leidner (2007) entitled “
7603 III, 10. 3. 2 | Ostermann, B, Mielke, H. (2005): Rückstände von Flammschutzmitteln I
7604 III, 10. 3. 2 | September 2005. htt ~ ~Vieth B, Rüdiger, R, Ostermann, B, Mielke,
7605 IV, 11. 6. 5 | Jørgensen T, Jovell A, Malone J, Rüther A, Wild C. Best practice
7606 II, 5. 9. 7 | 414-21.~ ~Anderson HR, Ruggles R, Strachan DP, Austin JB,
7607 III, 10. 2. 1 | LA, Mesana MI, Fleta J, Ruiz JR, González-Gross M, Sarría
7608 IV, 13. 5 | these issues. Successive rulings from the European Court
7609 III, 10. 2. 1 | 2005). Available at: http://rum.ctsu.ox.ac.uk/~tobacco/.~ ~
7610 II, 5. 5. 3 | 33.~Leucht S, Stiegler M, Rummel C, Wahlbeck K, Kissling
7611 IV, 11. 6. 5 | Care 5:159-65.~ ~Wilson RM, Runciman WB et al., (1995): "The
7612 II, 9. 3. 3 | Layte R, McGee H, Qual A, Rundle K, Cousins G, Donnelly C,
7613 III, 10. 5. 1 | Walinder R, Gunnarsson K, Runeson R, Smedje G (2007) Physiological
7614 III, 10. 3. 4 | outbreaks, extreme rainfall and runoff events may increase the
7615 II, 5. 6. 6 | Schulenburg JM, Zeidler H, Ruof J (2005): Direct Costs Related
7616 II, 5. 2. 7 | K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P (1999): Contribution
7617 III, 10. 3. 1 | Pershagen G, Ruano-Ravina A, Ruosteenoja E, A Schaffrath Rosario
7618 II, 5. 5. 3 | injuries and stress fractures, ruptured oesophagus, high blood pressure,
7619 II, 7. 4. 4 | instance osteoarthritis after ruptures of rotator cuff, often result
7620 III, 10. 5. 2 | www.nwpho.org.uk/reports/ruralhealth.pdf] (accessed on 12 November
7621 III, 10. 2. 1 | discharge of adrenaline. The rush of adrenaline stimulates
7622 II, 8. 2. 1 | Fujiura, G.T., Park, H. J. and Rutkowski-Kmitta, V. (2005). Disability Statistics
7623 II, 5. 14. 3 | children in Leicestershire and Rutland (United Kingdom) was about
7624 II, 5. 6. 6 | Nessiøy I, Bruusgaard D, Rutle O (1995): Musculoskeletal
7625 II, 5. 5. 3 | Weinmann S, Sartorius N, Rutz W, McIntyre JS (2005): Schizophrenia
7626 II, 5. 11. 7 | Handbook of atopic eczema eds T Ruzicka, J Ring, B Pryzbilla). London:
7627 II, 5. 6. 6 | Andries F, van Agt HM, Bijl RV, de Boer JB, Foets M, Hoeymans
7628 III, 10. 4. 5 | Association (Iceland, Norway,~ETC/RWM~The European Topic Centre
7629 II, 5. 10. 7 | Madsen C, Botjes E, Crevel RWR, van Ree R (2007): The prevalence,
7630 II, 5. 5. 3 | Keet IPM, Gheorghe MD, Rybakowski JK, Galderisi S, Libiger
7631 II, 5. 11. 3 | of Contact Dermatitis, RG Rycroft, T Menné, PJ Frosch, J-P
7632 II, 5. 10. 3 | containing wheat, barley and rye alcohol-soluble proteins.
7633 II, 9. 2. 7 | fit for children (A/RES/S-27/2). Available at:~htt ~ ~
7634 II, 8. 2. 1 | D, Bainbridge D, Cooper S-A, Davis R, Fujiura G, Heller
7635 II, 5. 5.Int(15)| Hooijer C, Lawlor BA, Kivela S-L, Lobo A, Magnusson H, Mann
7636 III, 10. 3. 2 | medium concentrations of for S-PBDE of 2.49 ng/g fat which is
7637 II, 8. 2. 1 | D.L., Craig, E.M., Gomez, S.C., Lachapelle, Y., Reeve,
7638 II, 7. 2. 1 | consequences of external causes ~ (S00-T98).~- Chapter XX: External
7639 II, 5. 2. 7 | Metab Cardiovasc Dis 18: S1-16.~Puska P, Vartiainen E,
7640 III, 10. 1. 3 | Metab Disord 23 Suppl 8: S1-S107.~Rehm J, Ashley MJ, Room
7641 II, 5. 7. 7 | Kidney Dis 2006;47(Suppl 3):S1-S145.~National Kidney Foundation.
7642 II, 5. 9. 7 | doi:10.1186/1471-2466-6-S1-S2).~ ~Jarvis D, Luczynska
7643 II, 5. 7. 7 | Kidney Dis 2003;42(Suppl 3):S1-S202.~National Kidney Foundation.
7644 II, 5. 7. 7 | Kidney Dis 2002;39(Supple 1):S1-S266.~National Kidney Foundation.
7645 II, 5. 7. 7 | Kidney Dis 2004;43(Suppl 1):S1-S290.~Obrador GT, Pereira BJ,
7646 III, 10. 2. 1 | J Clin Nutr 56 Suppl 2: S1-S3.~ ~European Commission (
7647 II, 5. 7. 7 | diabetes-2006. Diabetes Care 2006;29:S1-S85.~Annual data report 2005.,
7648 II, 5. 7. 7 | Kidney Dis 2003;41(suppl 3):S1-S92.~National Kidney Foundation.
7649 II, 9. 4. 7 | Gesundheitswesen 2005; 67 S1: S110-S114~ ~Volkert D (2005): Abstract:
7650 II, 5. 7. 7 | Nephrol 2003;14(7 Suppl 2):S131-S138.~Chen J, Wildman RP, Gu
7651 II, 5. 5. 3 | EDMUS. Ann Neurol 36(suppl):S136–S139.~Confavreux C, Vukusic
7652 II, 5. 5. 3 | Ann Neurol 36(suppl):S136–S139.~Confavreux C, Vukusic S,
7653 II, 5. 5. 3 | Epilepsia 38(suppl 11):S15-S19.~Olafsson E, Hauser WA,
7654 II, 5. 5. 3 | of Psychiatry 191 (50): s15-s20.~Prince M, Patel V, Saxena
7655 II, 5. 7. 7 | Int Suppl 2005 Dec;(99):S16-S19.~Pontoriero G, Pozzoni P,
7656 II, 5. 6. 6 | Study. Arthritis Rheum 34, S171~ ~Spector TD, Hart DJ, Powell
7657 II, 5. 12. 7 | countries. Addiction 96 Suppl 1:S19-33.~ ~Sauer P, Hansmann J,
7658 II, 5. 9. 7 | Medicine 2006, 6(Suppl 1):S2 doi:10.1186/1471-2466-6-
7659 II, 5. 9. 7 | Immunol. 2001 Jul;108(1 Suppl):S2-8.~ ~Torén K (2004): A prospective
7660 II, 5. 2. 7 | Int J Epidemiol 18 (suppl):S20–S28.~Thom TJ, Epstein FH,
7661 III, 10. 1. 3 | pressure. J Hum Hypertens 19:S20-S24.~Gidding SS, Morgan W, Perry
7662 II, 5. 4. 8 | Res Clin Pract 2006; 74:S200-S204.~Morris AD, Boyle DI, MacAlpine
7663 II, 5. 4. 8 | Practice, Volume 74, Pages S215 – S219~Carstensen B, Kristensen
7664 II, 5. 4. 8 | Volume 74, Pages S215 – S219~Carstensen B, Kristensen
7665 III, 10. 1. 3 | Metab Disord 22 Suppl 2:S22-S29.~Bondy SJ (1996): Overview
7666 II, 5. 7. 7 | Int Suppl 2005 Sep;(98):S25-S29.~Diez Roux AV, Chambless
7667 II, 5. 2. 7 | Epidemiol 18 (suppl):S20–S28.~Thom TJ, Epstein FH, Feldman.
7668 II, 5. 5. 3 | Wirksamkeit. Psychiat Prax 34(1):S28-S32.~Priebe S (2007): Social
7669 II, 5. 7. 7 | Int Suppl 2005 Apr;(94):S28-S35.~Garcia-Lopez F. Epirce.
7670 II, 5. 5. 3 | Annual Meeting: Abstract S28A.~Lehman AF, Steinwachs DM,
7671 II, 5. 11. 7 | Dermatol Venereol 2005;19(S3):2-6.~ ~Gudjonsson JE, Elder
7672 III, 10. 4. 3 | Toxicology Letters 164S: S324-S325~Valent F, et al (2004):
7673 II, 5. 5. 3 | Mov Disord 22 Suppl 17:S343-350.~Global Parkinson’s Disease
7674 II, 5. 2. 7 | Int J Epidemiol 30 (1):S35-S40.~Giampaoli S, Palmieri L,
7675 II, 5. 7. 7 | Nephrol 2002;13(Suppl 1):S37-S40.~McKenna AM, Keating LE,
7676 II, 5. 8. 7 | survey. Respir Med 2003; 97: s43-50.~ ~De Marco R, Accordini
7677 II, 5. 5. 3 | years. Acta Psych Scand 116(s435):33-40.~Lysaker PH, Tsai
7678 II, 5. 11. 7 | Br J Dermatol 1994;131(S44):34.~ ~Johnson M-LT (1978):
7679 II, 9. 1. 2 | Obstet Gynecol Repr Biol, 111:S45-S52 [on line publication available
7680 II, 5. 4. 8 | Diabetologia, 2002; 45(7): S5-12.~ ~Jonsson PM (2000), Marke
7681 III, 10. 2. 1 | Exercise, 31(11 Suppl.):S526-S533.~ ~Sjöström M et al. (2006):
7682 III, 10. 1. 3 | Sports Exerc 31(11) Suppl 1:S534-541.~King NA (1998): The relationship
7683 II, 5. 11. 7 | Br J Dermatol 2002;146(S61):1-6.~ ~Ferlay J, Bray F,
7684 II, 5. 7. 7 | Int Suppl 2004 Nov;(92):S7-10.~Gansevoort RT, Verhave
7685 III, 10. 2. 1 | Metabolic Disorders 28(Suppl. 1):S71.~ ~Kapantais E, Tzotzas
7686 II, 5. 5. 3 | survey. Epilepsy Behav 1:S9-S14.~Forsgren L, Bucht G, Erksson
7687 II, 5. 5. 3 | Neurol Scand 109:378-384.~De Sã J, Paulos A, Mendes H, et
7688 II, 5. 5. 1 | serious physical illness (Saarni et al, 2006). In addition,
7689 III, 10. 2. 1 | Bartrina J, Pérez Rodrigo C, Saavedra Santana P, Peña Quintana
7690 III, 10. 2. 1 | dietary record~7~Turrini A, Saba A, Perrone D, Cialfa E,
7691 II, 9. 2. 3 | violence and street violence. Sadly, very little is known about
7692 II, 5. 5.Int | feeling of helplessness, sadness, anxiety and the need to
7693 III, 10. 3. 2 | Pettersson, U Wass, M Luna, JC Saenz, J Santamaria (2002): Environmental
7694 II, 5. 8. 7 | G, Ligabue G, Ciaccia A, Saetta M, Papi A (2003): Differences
7695 II, 9. 3. 3 | not exposed to the heavy safe-sex messages of the 1980s when
7696 II, 9. 5. 6 | Studies, Vol 12(3): 377-395; SAGE Publications~ ~Lindholm
7697 II, 5. 9. 2 | Excluded:~Allergic asthma SAI 493.9~Detergent asthma 507.
7698 III, 10. 2. 1 | AB, Boeing H, Kolyva M, Saieva C, Celentano E, Ocke MC,
7699 III, 10. 4. 2 | S, Nakajima, S, Uno, A, Saijo, Y, Sata, F, Yoshimura,
7700 III, 10. 3. 4 | balloons, accidents involving sailing boats, ferries, cruise ships,
7701 III, 10. 6. 1 | support and parental stress (Saisto et al., 2008).~ ~Social
7702 IV, 11. 4 | institutional context. For the sake of utility, HTA designs
7703 IV, 11. 6. 5 | Saltman, J. Figueras and C. Sakellarides. Buckingham, Open University
7704 IV, 12. 10 | and representatives from SALAR (Swedish Association of
7705 II, 9. 3. 3 | Press; p37-67.~Cameron KA, Salazar LF, Bernhardt JM, Burgess-Whitman
7706 II, 5. 5. 3 | Dowding CH, Shenton CL, Salek SS (2006): A review of the
7707 II, 6. 3. 7 | or direct contact with saliva of, an infected animal.
7708 III, 10. 4. 2 | 2000b; Nielen et al., 2003;~Salleras et al., 1995~ ~ ~Process
7709 III, 10. 1. 3 | Williams DM, Dubbert PM, Sallis JF, King AC, Yancey AK,
7710 II, 8. 2. 3 | Quaranta A, Assennato G, Sallustio V (1996): Epidemiology of
7711 -, 1 | Walter Ricciardi, Stefania Salmaso, Emanuele Scafato, Benedetto
7712 III, 10. 2. 5 | Mäntymaa M, Puura K, Luoma I, Salmelin R, Davis H, Tsiantis J,
7713 III, 10. 4. 2 | hens infected with the main salmomenna types.~Eggs, poultry, turkey
7714 II, 5. 5. 3 | Ruhrmann S, Schultze-Lutter F, Salokangas RK, Linszen D, Birchwood
7715 II, 5. 8. 7 | Geijer RM, Sachs AP, Hoes AW, Salome PL, Lammers JW, Verheij
7716 III, 10. 6. 1 | 61(1):17-36.~ ~Kaplan GA, Salonen JT, Cohen RD, Brand RJ,
7717 III, 10. 4. 3 | wetlands as well as causing salt-water intrusion into coastal aquifers.
7718 II, 9. 2. 2 | static and undeveloped. Also salutary was the fact that this major
7719 II, 8. 2. 1 | Aussilloux, C., Määttä, T., Salvador-Carulla, L., Garrido-Cumbrera, M.,
7720 IV, 12. 10 | environment promotion index (SAM index)~ ~Requirements/control/
7721 II, 5. 5. 3 | withdrawal, insistence on sameness and language problems. These
7722 II, 5. 5. 3 | Finnmark, largely populated by Sami, a genetically resistant
7723 IV, 12. 10 | arbejdsmiljøcertifikat efter bekg. 923 samt 924 skal have truffet beslutning
7724 II, 5. 12. 7 | G, Messner M, Launois B, Samuel D, Cherqui D, et al (1999):
7725 III, 10. 2. 1 | E, Klipstein-Grobusch K, San-Jose B, Welch AA, Krogh V, Luben
7726 III, 10. 2. 1 | Trichopoulou A, Tumino R, Navarro Sanchez C, Martinez Garcia C, Mattisson
7727 II, 5. 12. 7 | de la Pena J, Brullet E, Sanchez-Hernandez E, Rivero M, Vergara M,
7728 II, 5. 5. 3 | severe learning disability (Sanchéz-Valle et al, 2007).~ ~ ~ ~
7729 II, 5. 5. 3 | Learning Disabilities, London.~Sánchez-Valle E et al (2007): Estimating
7730 III, 10. 4. 2 | cosmetic additives and soil and sand stabilisation. The degradation
7731 II, 5. 5. 3 | Suppl 1:74-77.~Andrews G, Sandersson K, Corry J, Issakidis C,
7732 I, 2. 9 | geographic distribution of the sandfly vector are occurring in
7733 II, 9. 3. 3 | F, McManus T, Markert S, Sandfort T, et al (1994) : Sexual
7734 IV, 11. 6. 2 | burden on the labour market (Sandier et al 2004). Since then,
7735 II, 5. 5. 3 | A, Dybbro J, Nilsson LL, Sandlund M, Sörgaard KW (2001):The
7736 II, 5. 5. 3 | questionnaire~62 ~3.7Ø ~Ochoa Sangrador and Luaces, 1991 (*)~Spain ~
7737 I, 2. 10. 4(10)| Febrero 2006. Ministerio de Sanidad y Consumo, Madrid 2006~
7738 II, 5. 7. 5 | the Istituto Superiore di Sanità. As for ESRD, reporting
7739 III, 10. 4. 2 | Ireland~Autoritatea Nationala Sanitar-Veterinara si pentru Siguranta Alimentelor~
7740 III, 10. 4. 2 | Malta~Główny Inspektorat Sanitarny~Poland~Autoridade de Segurança
7741 III, 10. 2. 4 | Spinelli JJ, Willett E, De Sanjose S, Cocco P, Berndt SI, Brennan
7742 III, 10. 3. 1 | Tampere, 2006.~Bray F, Sankila R, Ferlay J, Parkin DM (
7743 I, 2. 10. 4(20)| Value Chain “, Dr. Alberto Sanna, Scientific Institute Hospital
7744 III, 10. 3. 2 | Wass, M Luna, JC Saenz, J Santamaria (2002): Environmental risk
7745 III, 10. 2. 1 | Pérez Rodrigo C, Saavedra Santana P, Peña Quintana L (2003):
7746 II, 5. 5. 3 | sclerosis in the District of Santarem, Portugal. J Neurol 253:
7747 II, 9. 1. 2 | 1980-1999", Revues Epidem Sante Publique, Vol 53, pp 2S87-2S95.~
7748 II, 5. 7. 7 | Zanchetti A, Lombardi C, De Santo NG (2006): Low glomerular
7749 III, 10. 2. 1 | French).~ ~do Carmo I, dos Santos O, Camolas J, Vieira J,
7750 III, 10. 4. 2 | intussusception~ ~ ~ ~Sapovirus~GE~ ~ ~Low~ ~Prions~ ~ ~
7751 II, 5. 5. 3 | Kohn R, Saxena S, Levav I, Saraceno B (2004): The treatment
7752 II, 5. 5. 3 | Can J Neurol Sci 20:17-29.~Sarasoja T, Wikström J, Paltamaa
7753 III, 10. 6. 1 | improving community health in Sarasota, Florida: “crime prevention
7754 II, 5. 5. 3 | Puente E, Lopez de Munain A, Sarasqueta C, de Arce A, Poza JJ, Marti-Masso
7755 III, 10. 1. 3 | 90.~Melzer K, Kayser B, Saris WHM, Pichard C (2005): Effects
7756 II, 5. 5. 2 | in France where President Sarkozy recently pledged to add
7757 II, 5. 10. 7 | Hook-Nikanne J, Salomaa A, Sarna S, Aromaa A, Haahtela T (
7758 II, 5. 12. 7 | Forte P,~Pisani A, Soldo L, Sarrecchia B, et al (1989): Decline
7759 III, 10. 2. 1 | Ruiz JR, González-Gross M, Sarría A, Marcos A, Bueno M, for
7760 IV, 11. 6. 5 | W5-97-W5-107.~ ~Taggiasco Nì, Sarrut B et al. (1992): "European
7761 II, 6. 3. 4 | from animal reservoirs of SARS-CoV-like viruses. It remains very
7762 III, 10. 4. 2 | Okada, F, Ito, R, Kato, S, Sasaki, S, Nakajima, S, Uno, A,
7763 II, 5. 5. 3 | sclerosis in the province of Sassari, northern Sardinia. Neuroepidemiology
7764 III, 10. 4. 2 | Nakajima, S, Uno, A, Saijo, Y, Sata, F, Yoshimura, Y, Kishi,
7765 IV, 12. 10 | program with the title “Satellites for Epidemiology and health
7766 III, 10. 4. 2 | 2006~ ~In the past, Member Sates adopted national measures
7767 III, 10. 1. 1 | which have a weak effect on satiation, may cause exercise-induced
7768 II, 5. 5. 3 | some of which have shown satisfactorily preliminary results: lamotrigine,
7769 III, 10. 2. 1 | MG, Forouhi NG, Greer IA, Sattar N (2005): Changes in booking
7770 III, 10. 2. 1 | Schlesinger C, Heather N, Saunders J, Burnand B (2007): Effectiveness
7771 I, 2. 11 | 5-12~Suhrcke M, McKee M, Sauto Arce R, Tsolova S, Mortensen
7772 II, 5. 5. 3 | sclerosis in South Lower Saxony, Germany. Neuroepidemiology
7773 II, 9. 2. 3 | Europe (40%) are reported as saying they have very little or
7774 III, 10. 2. 1 | intake~ ~Based on EUROSTAT SBA, the gross human apparent
7775 II, 5. 11. 4 | hands. Atopic eczema and scabies are intensely itchy disorders,
7776 -, 1 | Stefania Salmaso, Emanuele Scafato, Benedetto Terracini, Lorenzo
7777 I, 2. 10. 3 | worker-centric, flexible, scalable and adaptable tools and
7778 II, 7. 4. 1 | children at home (falls, scalds, suffocation, poisoning,
7779 III, 10. 4. 2 | Monitoring; 2002 catch~limits for scallops in~Scotland~ ~Van Apeldoorn
7780 II, 9. 1. 2 | Congenital Malformations", Scandanavian Journal of Work & Environmental
7781 II, 5. 8. 5 | among continuing smokers (Scanlon et al, 2000).~ ~An interesting
7782 II, 5. 6. 3 | of the rib, clavicle and scapula (Woolf and Pfleger, 2003).~ ~
7783 II, 5. 2. 7 | References~Allender S, Scarborough P, Peto V and Rayner M (
7784 II, 5. 4. 4 | retinopathy and laser treatment scarcely available, flagging a gap
7785 III, 10. 4. 2 | notable decrease of “food scares” in recent years.~ ~The
7786 III, 10. 2. 4 | Spink C, Davis S, Bosch R, Scarpa A, Zhang Y, Severson RK,
7787 III, 10. 2. 1 | Gallus S, Colombo P, Scarpino V, Zuccaro P, Negri E, Apolone
7788 II, 5. 9. 4 | million people per year.~ ~The SCARPOL Study (Swiss Study on Childhood
7789 II, 5. 11. 3 | comedones (blackheads) and scars. It is caused by a combination
7790 II, 5. 11. 3 | any contact sensitization)~Schäfer T, et al~ ~Danish school
7791 III, 10. 3. 1 | Ruano-Ravina A, Ruosteenoja E, A Schaffrath Rosario A, Tirmarche M,
7792 II, 5. 8. 7 | 885.~ ~Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J (
7793 III, 10. 5. 3 | the exposure through work scheduling~ ~The main relevant European
7794 III, 10. 4. 2 | random~sampling~ ~Van der Schee, 2002;~KAP, 2003~ ~Veterinary
7795 II, 5. 5. 3 | Sloan F, Kulas E, Cutson T, Schenkman M (1997): The burden of
7796 IV, 11. 6. 4 | historical spend)~Latvia~State~SCHIA allocates funds to 8 regional
7797 II, 5. 5. 3 | 151.~Chio A, Magnani C, Schiffer D (1998): Prevalence of
7798 II, 5. 5. 3 | Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (
7799 II, 5. 5. 3 | Sept 6 2004.~Fangerau T, Schimrigk S, Haupts M, et al (2004):
7800 II, 5. 5. 3 | Marneros, A. et al,: Affektive, schizoaffektive und schizophrene Psychosen.
7801 II, 5. 5. 3 | Affektive, schizoaffektive und schizophrene Psychosen. Eine vergleichende
7802 II, 5. 5. 3 | contrast with the increasing schizophrenia-attributed mortality rates stated in
7803 II, 5. 5. 3 | et al quote “that 4.9% of schizophrenics will commit suicide during
7804 II, 5. 5. 3 | 2007): Psychotherapie bei Schizophrenien – Ergebnisse von Metaanalysen
7805 II, 5. 5. 3 | first-episode schizophrenia and schizophreniform disorder: an open randomised
7806 III, 10. 4. 2 | industry~and government~ ~Schlatter et al., 2002~ ~ ~ ~ ~Heterocyclic
7807 II, 5. 9. 7 | Richter K, Fahlbusch B, Schlenvoigt G, Bischof W, Wichmann HE (
7808 III, 10. 2. 1 | Pienaar E, Campbell F, Schlesinger C, Heather N, Saunders J,
7809 II, 5. 5. 3 | German Health Minister Ulla Schmidt, during the German Presidency
7810 III, 10. 1. 3 | 205-8.~Tappy L, Binnert C, Schneiter Ph (2003): Energy expenditure,
7811 II, 5. 5. 3 | 40:1388-1392.~Massey EW, Schoenberg BS (1985): Mortality from
7812 II, 8. 2. 1 | Data are available from scholarly articles, project reports
7813 I, 2. 10. 2 | International Centre for Scholars has compiled an inventory
7814 II, 8. 2. 1 | Retardation. Journal of Nursing Scholarship, First Quarter 2004, 48-
7815 IV, 11. 3. 1 | training, such as offering scholarships to medical students who
7816 II, 5. 8. 7 | Vermeeren MA, Creutzberg EC, Schols AM, Postma DS, Pieters WR,
7817 II, 5. 5. 3 | Koehne-Volland R, Szucs T, Rathay B, Scholz E, Oertel WH (1998): The
7818 II, 5. 9. 4 | 540) and 2004 (n=1,920) in school-children aged 9-11. Over these 15
7819 II, 5. 11. 3 | sensitization in a Danish schoolgirl population with ears pierced
7820 II, 8. 1. 3 | qualifications beyond compulsory schooling. Moreover, reduced participation
7821 II, 5. 7. 7 | e27.~Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B,
7822 III, 10. 5. 1 | classrooms on the performance of schoolwork by children (1257-RP).~ ~
7823 II, 5. 11. 7 | 794-800.~ ~de Rijke JM, Schouten LJ, Hillen HF et al (2000):
7824 III, 10. 2. 1 | Bueno-de-Mesquita HB, van der Schouw YT, Engeset D, Skeie G,
7825 II, 5. 6. 6 | 1141~Merx H, Dreinhofer K, Schrader P, Sturmer T, Puhl W, Gunther
7826 III, 10. 3. 2 | F Petrucci, B Bocca, P Schramel, M Zischka, C Pettersson,
7827 III, 10. 2. 4 | Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst
7828 III, 10. 2. 4 | 15(2):114-116.~ ~Brand A, Schröder P, Brand H, Zimmern R (2006):
7829 II, 9. 4. 7 | Verheijden Mw., De Henauw S., Schroll M., Van Staveren Wa. (2004):
7830 II, 5. 2. 6 | Smith B, Maheshwari N, Schrott H (2005). Pleiotropic effects
7831 III, 10. 2. 5 | 377-82~Madigan S, Moran G, Schuengel C (2007): Unresolved maternal
7832 II, 5. 5. 3 | Munk-Jørgensen P, Bertelsen A, Schürmann A, Michels R, Malchow CP,
7833 II, 9. 3. 2 | Bouvier-Colle et al, 1995; Schuitmaker, 1998).~ ~The main definition
7834 II, 5. 5. 3 | Klosterkötter J, Ruhrmann S, Schultze-Lutter F, Salokangas RK, Linszen
7835 IV, 12. 1 | and steel that led Robert Schuman, the French Foreign Minister,
7836 IV, 12. 10 | Gesetz zum zivilrechtlichen Schutz vor Gewalttaten und Nachstellungen,
7837 II, 5. 8. 7 | Kreiss K, Mapp C, Milton D, Schwartz D, Toren K, Viegi G (2003):
7838 III, 10. 2. 1 | Network HEPA Switzerland. Schweizerische Zeitschrift für Sportmedizin
7839 III, 10. 3. 1 | Berglund B, Lindvall T, Schwela D.~World Health Organization
7840 II, 9. 1. 2 | E, Rost van Tonningen M, Scialli A, Peters P (2001): Drugs
7841 III, 10. 4. 2 | believed at political level. Science-based control measures by the
7842 -, 1 | to provide a reliable and scientifically-sound picture of what is the status
7843 IV, 11. 1. 5 | biochemists and laboratory scientist. Medical information and
7844 I, 2. 10. 4(18)| De Scioli D. (2005). Differatiating
7845 II, 5. 15. 1 | most common ones there are: Sclerodermia, Charcot-Marie-Tooth disease,
7846 II, 5. 8. 7 | G, Mattelli G, Angino A, Scognamiglio A, Baldacci S, Soriano JB,
7847 III, 10. 5. 1 | salute respiratoria degli scolari (Studio pilota HESE). Available
7848 III, 10. 4. 5 | policies have other aims and scopes of action, they are not
7849 III, 10. 2. 1 | subscales was recorded. The best scoring countries, UK, Estonia,
7850 IV, 12. 1 | against the major health scourges, by promoting research into
7851 III, 10. 4. 2 | managers take decision (SCPHAW).~ ~Pesticides peer review
7852 III, 10. 4. 2 | As regards the TSEs (BSE, scrapie etc), the following actions
7853 II, 5. 3. 2 | data:~- early indicators: screen-detected incidence as a proportion
7854 II, 5. 2. 6 | Findings in 356,222 primary screenees of the Multiple Risk Factor
7855 IV, 12. 5 | December 2003 on cancer screening1; collect data on health
7856 II, 5. 5. 3 | past three decades were scrutinized, out of which a third turned
7857 III, 10. 2. 1 | restricted or under Community scrutiny. At the end of a transitional
7858 III, 10. 2. 1 | Richards M, Ringborg U, Scully C, Siracka E, Storm H, Tubiana
7859 III, 10. 4. 5 | discolouring of water, scum formation and unpleasant
7860 III, 10. 5. 1 | qualità dell’aria nelle scuole europee e sue implicazioni
7861 III, 10. 4. 3 | catchment to consumer. WHO/SDE/WSH/05.06. Available at: htt ml~
7862 III, 10. 2. 1 | the application of dental sealants are additional means for
7863 III, 10. 5. 1 | emissions and urban pests. Sealed land and contaminants are
7864 III, 10. 3. 2 | mammalian top predators, such as seals, whales, dolphins and polar
7865 II, 9. 4. 5 | directly on the provision of seamless or continuous care. This
7866 II, 5. 9. 2 | children and adults by Medline searches for the period between 1
7867 II, 7. 4. 7 | Recommended entry points for searching policy guidance on suicide
7868 II, 5. 11. 1 | vessels, nerves, sweat and sebaceous glands, all of which can
7869 III, 10. 5. 1 | 26(4): 285-300~ ~Zhao Z, Sebastian A, Larsson L, Wang Z, Zhang
7870 II, 5. 11. 3 | insect bites, dandruff (seborrheic eczema of the scalp), dry
7871 III, 10. 2. 1 | europa.eu/sport/whitepaper/sec934_en.pdf].~ ~Evans J, Roberts
7872 II, 8. 2. 1 | also the most likely to be secluded in large institutions, unable
7873 II, 5. 5. 3 | assigned to treatment with second-generation antipsychotic drugs (Kahn
7874 II, 5. 5. 3 | continuing progression; (c) secondary-progressive MS (SP-MS), initial RR course
7875 -, 1 | assistance of Beniamino Cislaghi, seconded from the World Health Organization -
7876 IV, 12. 4 | 7). Working as technical secretariats rather than big centralised
7877 II, 9. 3. 1 | depletion. Estrogen-dependent secretions decrease, leading to vaginal
7878 II, 9. 3. 1 | hyperplastic and may be secretory until the year before menopause.
7879 III, 10. 2. 1 | for the Grupo Colaborativo SEEDO (2005): Prevalencia de obesidad
7880 II, 5. 10. 5 | products thereof~- Sesame seeds and products thereof~- Sulphur
7881 III, 10. 2. 1 | drug for which treatment is seeked. Of the total approximately
7882 II, 9. 3. 2 | illegal resident or an asylum seeker would not be counted. Audits
7883 III, 10. 3. 1 | exposure caused by radon gas seeping into the building, can be
7884 III, 10. 3. 1 | decay of uranium; radon seeps out of the ground in areas
7885 II, 5. 5. 3 | present budgets.~The costs as segmented according to different health
7886 II, 5. 15. 3 | due to a single mutation segregating in family members. These
7887 III, 10. 4. 2 | Sanitarny~Poland~Autoridade de Segurança Alimentar e Económica~Portugal~The nd~
7888 III, 10. 4. 2 | Slovenia~Agencia Española de Seguridad Alimentaria y nutricion~
7889 III, 10. 2. 1 | Viet LA, Kroesbergen HT, Seidell JC (2006): Underreporting
7890 II, 5. 5. 3 | region round the town of Seinäjoki, intermediate rates in central
7891 I, 2. 10. 4 | 2.7 million items were seized by European Customs, a 384%
7892 II, 5. 5. 3 | states require a two-year seizure-freedom period before granting or
7893 II, 5. 5. 3 | triggered by a seizure with seizure-induced cardio-respiratory alterations
7894 II, 5. 6. 3 | million) in 1994, of which SEK739 million (Euro 59.6 million)
7895 II, 9. 3. 3 | Haavio-Mannila E, Kontula O (2001): Seksin trendit meillä ja naapureissa (
7896 III, 10. 2. 1 | 2003; Whelton et al, 2007). Self- or parental-reported anthropometric
7897 III, 10. 2. 1 | for data collection (e.g. self-administered questionnaires, telephone
7898 II, 5. 5. 3 | possibilities for empowerment and self-advocacy. But emphasis must be placed
7899 IV, 11. 1. 5 | generally measured: subjective/self-assessed and objective/clinical outcomes.~ ~
7900 II, 9. 2. 7 | physical effectiveness, and self-concept in late adolescents. Adolescence,
7901 II, 5. 4. 6 | diabetes;~· how to deal with self-control and self-regulation;~· what
7902 II, 5. 4. 6 | situations.~· Education and self-education are a separate part of treatment
7903 II, 9. 3. 3 | reduction strategies, increased self-effectiveness and intention to adopt safer
7904 II, 5. 5. 3 | their problems, and their self-evaluation is over influenced by body
7905 II, 9. 4. 5 | the countries, it seems self-evident that structural change -
7906 IV, 11. 6. 4 | governments, directives by self-governing bodies or national/local
7907 III, 10. 2. 1 | Roberts, 1987), positive self-image among women (Maxwell and
7908 II, 6. 3. 6 | infection is mostly mild and self-limiting, but may lead to abortion
7909 II, 5. 9. 5 | management. Most asthma cases are self-managed by patients with the support
7910 II, 5. 1. 3 | patients in the skills of self-managing or adapting the treatment
7911 II, 5. 4. 2 | recruitment on the basis of self-motivation can be very prone to selection
7912 II, 8. 1. 3 | affected by differences in self-perception of the health and disability
7913 II, 5. 5. 1 | Europe hanging, shooting and self-poisoning are the most used suicide
7914 IV, 12. 10 | Work environment factors~Self-rated work-related ill-health~ ~
7915 III, 10. 2. 1 | differences in the validity of self-reports have been identified (Bostrom
7916 II, 5. 5. 3 | stigma has also evaluated self-stigmatization in people afflicted by mental
7917 I, 2. 7 | greenhouse-emission transit and self-sufficient water and energy systems.
7918 III, 10. 1. 1 | influence, sociability, self-worth, control/responsibility,
7919 II, 5. 5. 3 | Orphanet (2007): Prävalenzen seltener Krankheiten: eine Literaturstudie.
7920 I, 2. 10. 3 | Software and services.~- Semantic-based knowledge and content systems.~ ~
7921 III, 10. 3. 2 | Worldwide, a decline in semen quality has been observed
7922 I, 2. 4 | prepared by APPLICA, 2005; Semenza and Giesecke, American Journal
7923 II, 5. 6. 3 | Table 5.6.9). There are some semi-independent risk factors for fracture
7924 III, 10. 5. 1 | stable residence. Nomadic and semi-nomadic populations such as the
7925 III, 10. 4. 2 | photographic industry, in semiconductor photolithography and aviation
7926 I, 2. 10. 2 | Quantum dots: Nanosized semiconductors (also named nanocrystals),
7927 IV, 11. 6. 5 | going private? LSE Formal Seminar, May 17, London.~ ~Kohn
7928 II, 5. 2. 2 | the majority of countries send to the European organizations (
7929 II, 5. 4. 1 | feet. Because of abnormal sensation (nerve function) or blood
7930 III, 10. 4. 2 | concentrations: tingling~sensations, respiratory~paralysis,
7931 IV, 13. 5 | contribute to the gradual loss of senses such as sight and hearing,
7932 II, 5. 10. 2 | European consumers. The major sensitising foods identified were cow’
7933 I, 2. 3 | make them able to respond sensitively to the needs of immigrant
7934 IV, 12. 10 | advertising gifts, with an aim to sensitize and educate the citizens
7935 II, 6. 3. 6 | returning travellers used as sentinels, indicate a very large under-reporting
7936 II, 8. 1. 1 | ICF) (WHO, 2001), which separates the notion of functional
7937 II, 5. 5. 3 | 952.~Peterlin B, Ristic S, Sepcic J, et al (2006): Region
7938 III, 10. 5. 1 | Tuomisto, JT, Yli-Tuomi, T, Seppänen, O, Jantunen, MJ (2005):
7939 IV, 11. 6. 5 | Joint Meeting in Prague, 29 September-3 October 2007.~ ~Gosden T,
7940 III, 10. 3. 4 | flooded and contaminated by septic pits. The resulting economic
7941 II, 5. 11. 1 | dehydration to heart failure, septicaemia and death.~Skin disease
7942 II, 5. 4. 7 | relevant:~· EUDIP, with its sequel EUCID, which, as shown before
7943 III, 10. 1. 1 | an ongoing discussion if sequential (non-integrated) or simultaneous
7944 III, 10. 1. 3 | 13(6):291-295.~Wiers RW, Sergeant JA, Gunning WB (1994): Psychological
7945 II, 5. 9. 4 | underwent skin prick tests and serological assays) presented a low
7946 IV, 11. 5. 4 | candidates due to positive serology, congenital and inherited
7947 II, 5. 6. 3 | the genetic components of seropositive RA has been mapped to a
7948 II, 6. 3. 6 | salmonellosis epidemiology, and this serotype has been by far the most
7949 III, 10. 2. 1 | Aranceta-Bartrina J, Serra-Majem L, Foz-Sala M, Moreno-Esteban
7950 III, 10. 5. 3 | relationship (but for domestic servants). The employer determines
7951 IV, 11. 6. 4 | through many national health service-type systems is not based on
7952 II, 5. 10. 5 | Mustard and products thereof~- Sesame seeds and products thereof~-
7953 II, 5. 9. 7 | Bettoncelli G, Cricelli C, Sessa E, Mazzaglia G, Canonica
7954 III, 10. 2. 1 | example, well include some sessions of activity or exercise
7955 III, 10. 5. 1 | M, Viegi G, Canciani M, Sestini P (2006): La qualità dell’
7956 III, 10. 4. 2 | Persistent Organic Pollutants. SETAC Europe Workshop, Milan,
7957 IV, 12. 10 | Health. The High Council setq up a report about health
7958 II, 9. 3. 3 | Roberts C, Morgan A, Smith R, Settertobultr W, Samdal O, Barnekow Rasmussen
7959 IV, 12. 10 | decision 1217/09/2006 for the setting-up mechanism for the promotion
7960 II, 5. 8. 7 | Sandstrom T, Lundback B (2006): Seven-year cumulative incidence of
7961 III, 10. 2. 1 | This represents a more than sevenfold increase since 1993, when
7962 II, 5. 8. 3 | moderate 4.5 and 2.2%, severe-very severe 0.4 and 0.3% (Zielinski
7963 II, 5. 11. 7 | 1992;72:456-60.~ ~Plesko I, Severi G, Obsitnikova A, Boyle
7964 II, 9. 1. 2 | distinguish between different severities of the same anomaly. Data
7965 III, 10. 2. 4 | Bosch R, Scarpa A, Zhang Y, Severson RK, Yeager M, Chanock S,
7966 II, 5. 5. 1 | Angermeyer MC, Haro JM, Sevilla-Dedieu C, the ESEMeD/MHEDEA 2000
7967 II, 5. 5. 3 | Claveria LE, Duarte J, Sevillano MD, Perez-Sempere A, Cabezas
7968 III, 10. 4. 5 | other pathogens derived from sewers, animal waste, the environment
7969 II, 5. 6. 3 | fractures. The age-adjusted and sex-adjusted incidence rates for vertebral
7970 II, 5. 3. 6 | years from 1983 to 1994. Sex-and-age-adjusted 5-year survival trends for
7971 II, 5. 6. 3 | Figure 5.6.1. The age and sex-specific prevalence of chronic musculoskeletal
7972 II, 9. 3. 3 | including modernisation of sexual-health services, reduced waiting
7973 II, 9. 3. 3 | use~ ~The proportion of sexually-active young people who report
7974 II, 5. 8. 3 | by Sprenkle et al (2004), SF-36V was used in a large cohort
7975 II, 5. 8. 3 | lower health status (total SGRQ > 60) and diabetes have
7976 III, 10. 4. 2 | the UK put TSEs out of the shadow, but only in 1996 the BSE
7977 II, 9. 1. 2 | 1991). During the 1990s, a shallow further decline was experienced
7978 II, 9. 5. 6 | Sporting Bodies: Dynamics of Shame and Pride. Body and Society,
7979 III, 10. 2. 4 | Prevention. Washington~ ~Gao J, Shan G, Sun B, Thompson PJ, Gao
7980 III, 10. 6. 1 | Available at: http://www.share-project.org/t3/share/index.php?id=
7981 II, 5. 5. 3 | with the aim to develop shareable guidelines and thereby save
7982 II, 7. 7 | Organization, Peden M, McGee K, Sharma G.~ ~Racioppi F, Eriksson
7983 II, 5. 2. 7 | 32.~Hozawa A, Folsom AR, Sharrett AR, Chambless LE (2007):
7984 III, 10. 2. 1 | nì Mhurchu C, Kalamara E, Shayeghi M, Rigby NJ, Nishida C,
7985 IV, 11. 1. 5 | Public and patient surveys shed light on the level of responsiveness
7986 II, 5. 11. 3 | dichromate from 1.3% in Sheffield (UK) to 9.1% in Liverpool (
7987 II, 5. 10. 7 | 7):633-637):~ ~Gupta R, Sheikh A, Strachan D, Ross Anderson
7988 II, 9. 2. 2 | gathering exercise each remains shelved and not further progressed.
7989 III, 10. 5. 1 | include floors, textiles, open shelves and other areas above the
7990 II, 5. 5. 3 | 5):384-386.~Dowding CH, Shenton CL, Salek SS (2006): A review
7991 II, 5. 2. 6 | S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J,
7992 I, 2. 11 | Gesler, W., Preisser, J., Sherman, J., Spencer, J., Perin,
7993 III, 10. 2. 1 | Tedstone A, Aviles M, Shetty P, Daniels L (1998): Effectiveness
7994 IV, 11. 6. 5 | 145-50.~ ~Starfield B, Shi L et al. (2005): "The Effects
7995 II, 7. 4. 3 | people without any protection shield, namely pedestrians and
7996 I, 3. 2 | past ten years, the balance shifted to migration as the most
7997 IV, 13. 2. 3 | Transmitted Disease: STEC: Shiga-toxin-producing Escherichia coli; PAHs:
7998 I, 2. 10. 4 | order processing, receiving/shipping management (simplification
7999 III, 10. 6. 2 | kindergarten have got the shirt, a group photo is taken
8000 IV, 12. 10 | tobacco use like snuff or shisha/waterpipe are also addressed.~
8001 IV, 12. 10 | of drugs (e. g. “Quit the shit”-program for Cannabis addictive
8002 II, 5. 7. 7 | CY, Vittinghoff E, Lin F, Shlipak MG (2004): The incidence
8003 II, 8. 2. 1 | R.L., Luckasson, R.A. and Shogren K.A., With Borthwick-Duffy,
